Pharmalot - STAT

Pharmalot By Ed Silverman

Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish

Pharmalot By Ed Silverman

WHO warns the world is still failing to develop desperately needed antibiotics

Pharmalot By Ed Silverman

FDA is urged to move faster to list medicines withdrawn over safety concerns

Pharmalot By Ed Silverman

Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause

Pharmalot By Ed Silverman

Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’

Pharmalot By Ed Silverman

Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots

Pharmalot By Ed Silverman

Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels

Pharmalot By Ed Silverman

A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs

Pharmalot By Ed Silverman

Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production

Pharmalot By Ed Silverman

Lilly is a holdout among companies that agree to disclose when executive pay is clawed back

Pharmalot By Ed Silverman

Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns

Pharmalot By Ed Silverman

Bristol Myers Squibb agrees to pay $75 million to settle allegations of underpaying Medicaid rebates

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot

Pharmalot By Ed Silverman

FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections

Pharmalot By Ed Silverman

Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill

Pharmalot By Ed Silverman

The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research

Pharmalot By Ed Silverman

Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal

Pharmalot By Ed Silverman

FTC seeks to block Illumina from buying Grail, citing threats to competition

Pharmalot By Ed Silverman

Most U.S. universities get an ‘F’ on ensuring access to drugs they discover

Pharmalot By Ed Silverman

Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing

Pharmalot By Ed Silverman

Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries

Pharmalot By Ed Silverman

Most Read

Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug

Clinical study reports hold more details about the side effects of cancer drugs

Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs

A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements

Pharmalittle: U.S. is prohibited from sharing Covid-19 shots with other countries; U.S. officials knew of problems at Emergent plant

California once again delays launch of a closely watched prescription drug purchasing program

All Coverage

Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish

WHO warns the world is still failing to develop desperately needed antibiotics

FDA is urged to move faster to list medicines withdrawn over safety concerns

Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause

Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’

Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot

Up and down the ladder: The latest comings and goings

Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots

Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels

A controversial court case in Brazil will tackle pharma ‘monopolies’ and access to drugs

Pharmalittle: EMA official says link exists between AstraZeneca Covid-19 shot and rare blood clots; Catalent to boost Moderna vaccine production

Lilly is a holdout among companies that agree to disclose when executive pay is clawed back

Pharmalittle: U.S. puts J&J in charge of plant that botched Covid-19 vaccines; pharmacies offering Covid shots raise privacy concerns

Bristol Myers Squibb agrees to pay $75 million to settle allegations of underpaying Medicaid rebates

Up and down the ladder: The latest comings and goings

Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot

FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections

Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill

The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research

Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal

FTC seeks to block Illumina from buying Grail, citing threats to competition

Most U.S. universities get an ‘F’ on ensuring access to drugs they discover

Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing

Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries

Congressional lawmakers urge FTC to investigate insulin makers over their pricing